more general categories |
information about this item |
|
C04. Neoplasms |
 |
 |
|
C04. Neoplasms |
|
|
|
|
|
Ovarian Cysts [MESH:D010048] (2534) |
|
|
|
|
|
|
|
|
|
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Breast Neoplasms [MESH:D001943] (6077) |
|
|
|
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
 |
C06. Digestive System Diseases |
 |
 |
|
C06. Digestive System Diseases |
|
|
|
|
|
|
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
|
|
|
Non-alcoholic Fatty Liver Disease [MESH:C541083] (1567) |
|
|
Liver Cirrhosis, Experimental [MESH:D008106] (4589) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
 |
C10. Nervous System Diseases |
 |
 |
|
C10. Nervous System Diseases |
|
|
|
|
|
|
|
|
|
|
|
Seizures [MESH:D012640] (4502) |
|
|
|
|
|
Hypopituitarism [MESH:D007018] (732) |
|
|
Seizures [MESH:D012640] (4514) |
|
 |
C12. Male Urogenital Diseases |
 |
 |
|
C12. Male Urogenital Diseases |
|
|
|
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Infertility, Male [MESH:D007248] (2851) |
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
|
|
|
|
|
|
Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) |
|
|
|
|
|
Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency [MESH:C535978] (62) |
|
|
Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) |
|
|
Adrenal hyperplasia, congenital, type 5 [MESH:C538237] (223) |
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
 |
C13. Female Urogenital Diseases and Pregnancy Complications |
 |
 |
|
C13. Female Urogenital Diseases and Pregnancy Complications |
|
|
|
|
|
|
|
|
|
|
|
Ovarian Cysts [MESH:D010048] (2534) |
|
|
Infertility, Female [MESH:D007247] (2184) |
|
|
|
|
|
|
|
|
Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) |
|
|
|
|
|
Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency [MESH:C535978] (62) |
|
|
Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) |
|
|
Adrenal hyperplasia, congenital, type 5 [MESH:C538237] (223) |
|
 |
C14. Cardiovascular Diseases |
 |
 |
|
C14. Cardiovascular Diseases |
|
|
|
|
|
|
|
|
Hypertension, Malignant [MESH:D006974] (621) |
|
 |
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
 |
 |
|
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) |
|
|
|
|
|
Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency [MESH:C535978] (62) |
|
|
Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) |
|
|
Adrenal hyperplasia, congenital, type 5 [MESH:C538237] (223) |
|
|
|
|
|
Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency [MESH:C535978] (62) |
|
|
Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) |
|
|
Adrenal hyperplasia, congenital, type 5 [MESH:C538237] (223) |
|
|
|
|
|
|
|
|
Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency [MESH:C535978] (62) |
|
|
Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) |
|
|
Adrenal hyperplasia, congenital, type 5 [MESH:C538237] (223) |
|
 |
C17. Skin and Connective Tissue Diseases |
 |
 |
|
C17. Skin and Connective Tissue Diseases |
|
|
|
|
|
Breast Neoplasms [MESH:D001943] (6077) |
|
 |
C18. Nutritional and Metabolic Diseases |
 |
 |
|
C18. Nutritional and Metabolic Diseases |
|
|
|
|
|
|
|
|
|
|
|
Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency [MESH:C535978] (62) |
|
|
Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) |
|
|
Adrenal hyperplasia, congenital, type 5 [MESH:C538237] (223) |
|
|
Hyperkalemia [MESH:D006947] (485) |
|
 |
C19. Endocrine System Diseases |
 |
 |
|
C19. Endocrine System Diseases |
|
|
|
|
|
Adrenal Insufficiency [MESH:D000309] (1599) |
|
|
Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency [MESH:C535978] (62) |
|
|
Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) |
|
|
Adrenal hyperplasia, congenital, type 5 [MESH:C538237] (223) |
|
|
|
|
|
Glucocorticoid-Remediable Aldosteronism [MESH:C563177] (62) |
|
|
Hypogonadism [MESH:D007006] (1123) |
|
|
|
|
|
Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) |
|
|
|
|
|
Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency [MESH:C535978] (62) |
|
|
Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) |
|
|
Adrenal hyperplasia, congenital, type 5 [MESH:C538237] (223) |
|
|
Ovarian Cysts [MESH:D010048] (2534) |
|
|
Hypopituitarism [MESH:D007018] (732) |
|
 |
C23. Pathological Conditions, Signs and Symptoms |
 |
 |
|
C23. Pathological Conditions, Signs and Symptoms |
|
|
|
|
|
Amenorrhea [MESH:D000568] (817) |
|
|
Oligomenorrhea [MESH:D009839] (228) |
|
|
|
|
|
Seizures [MESH:D012640] (4502) |
|
 |
D04. Polycyclic Compounds |
 |
 |
|
D04. Polycyclic Compounds |
|
|
|
|
|
|
|
|
|
|
|
Androstenedione [MESH:D000735] (76) |
|
|
|
|
|
Androstenedione [MESH:D000735] (76) |
|
 |
D06. Hormones, Hormone Substitutes, and Hormone Antagonists |
 |
 |
|
D06. Hormones, Hormone Substitutes, and Hormone Antagonists |
|
|
|
|
|
|
|
|
Androstenedione [MESH:D000735] (76) |
|
|
|
|
|
|
|
|
Androstenedione [MESH:D000735] (76) |
|
 |
F. Psychiatry and Psychology |
 |
 |
|
F. Psychiatry and Psychology |
|
|
|
|
|
|
|
|
|
|
|
Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) |
|
 |